Literature DB >> 23904166

Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.

Hai Huang1, Hui-Wei Chen, John Evankovich, Wei Yan, Brian R Rosborough, Gary W Nace, Qing Ding, Patricia Loughran, Donna Beer-Stolz, Timothy R Billiar, Charles T Esmon, Allan Tsung.   

Abstract

Cellular processes that drive sterile inflammatory injury after hepatic ischemia/reperfusion (I/R) injury are not completely understood. Activation of the inflammasome plays a key role in response to invading intracellular pathogens, but mounting evidence suggests that it also plays a role in inflammation driven by endogenous danger-associate molecular pattern molecules released after ischemic injury. The nucleotide-binding domain, leucine-rich repeat containing protein 3 (NLRP3) inflammasome is one such process, and the mechanism by which its activation results in damage and inflammatory responses following liver I/R is unknown. In this article, we report that both NLRP3 and its downstream target caspase-1 are activated during I/R and are essential for hepatic I/R injury, because both NLRP3 and caspase-1 knockout mice are protected from injury. Furthermore, inflammasome-mediated injury is dependent on caspase-1 expression in liver nonparenchymal cells. Although upstream signals that activate the inflammasome during ischemic injury are not well characterized, we show that endogenous extracellular histones activate the NLRP3 inflammasome during liver I/R through TLR9. This occurs through TLR9-dependent generation of reactive oxygen species. This mechanism is operant in resident liver Kupffer cells, which drive innate immune responses after I/R injury by recruiting additional cell types, including neutrophils and inflammatory monocytes. These novel findings illustrate a new mechanism by which extracellular histones and activation of NLRP3 inflammasome contribute to liver damage and the activation of innate immunity during sterile inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23904166      PMCID: PMC3777242          DOI: 10.4049/jimmunol.1202733

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.

Authors:  Masanori Kawaguchi; Masafumi Takahashi; Takeki Hata; Yuichiro Kashima; Fumitake Usui; Hajime Morimoto; Atsushi Izawa; Yasuko Takahashi; Junya Masumoto; Jun Koyama; Minoru Hongo; Tetsuo Noda; Jun Nakayama; Junji Sagara; Shun'ichiro Taniguchi; Uichi Ikeda
Journal:  Circulation       Date:  2011-01-31       Impact factor: 29.690

2.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

3.  Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation.

Authors:  Christoph L Menzel; Qian Sun; Patricia A Loughran; Hans-Christoph Pape; Timothy R Billiar; Melanie J Scott
Journal:  Mol Med       Date:  2011-06-07       Impact factor: 6.354

4.  High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Authors:  Wei Yan; Ying Chang; Xiaoyan Liang; Jon S Cardinal; Hai Huang; Stephen H Thorne; Satdarshan P S Monga; David A Geller; Michael T Lotze; Allan Tsung
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

5.  Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

Authors:  Ramanjaneyulu Allam; Christina Rebecca Scherbaum; Murthy Narayana Darisipudi; Shrikant R Mulay; Holger Hägele; Julia Lichtnekert; Jan Henrik Hagemann; Khader Valli Rupanagudi; Mi Ryu; Claudia Schwarzenberger; Bernd Hohenstein; Christian Hugo; Bernd Uhl; Christoph A Reichel; Fritz Krombach; Marc Monestier; Helen Liapis; Kristin Moreth; Liliana Schaefer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

Review 6.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

7.  PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes.

Authors:  Patricia A Loughran; Donna B Stolz; Stacey R Barrick; David S Wheeler; Peter A Friedman; Richard A Rachubinski; Simon C Watkins; Timothy R Billiar
Journal:  Nitric Oxide       Date:  2013-03-05       Impact factor: 4.427

Review 8.  Pathogenic anti-nucleosome antibodies.

Authors:  S Muller; J Dieker; A Tincani; P L Meroni
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

Review 9.  Toll-like receptors in ischemia-reperfusion injury.

Authors:  Thiruma V Arumugam; Eitan Okun; Sung-Chun Tang; John Thundyil; Stephen M Taylor; Trent M Woodruff
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

10.  Proteomic identification of interactions between histones and plasma proteins: implications for cytoprotection.

Authors:  Alan D Pemberton; Jeremy K Brown; Neil F Inglis
Journal:  Proteomics       Date:  2010-04       Impact factor: 3.984

View more
  92 in total

Review 1.  Role of innate immune system in systemic sclerosis.

Authors:  Nicola Fullard; Steven O'Reilly
Journal:  Semin Immunopathol       Date:  2015-07-10       Impact factor: 9.623

2.  An endogenous factor mediates shock-induced injury.

Authors:  Peter A Ward
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.

Authors:  Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

4.  Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN.

Authors:  Santhosh V R Kumar; Onkar P Kulkarni; Shrikant R Mulay; Murthy N Darisipudi; Simone Romoli; Dana Thomasova; Christina R Scherbaum; Bernd Hohenstein; Christian Hugo; Susanna Müller; Helen Liapis; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

Review 5.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

6.  Toxic effects of extracellular histones and their neutralization by vitreous in retinal detachment.

Authors:  Hiroki Kawano; Takashi Ito; Shingo Yamada; Teruto Hashiguchi; Ikuro Maruyama; Toshio Hisatomi; Makoto Nakamura; Taiji Sakamoto
Journal:  Lab Invest       Date:  2014-03-10       Impact factor: 5.662

Review 7.  Extracellular histones in tissue injury and inflammation.

Authors:  Ramanjaneyulu Allam; Santhosh V R Kumar; Murthy N Darisipudi; Hans-Joachim Anders
Journal:  J Mol Med (Berl)       Date:  2014-04-06       Impact factor: 4.599

Review 8.  Histones as mediators of host defense, inflammation and thrombosis.

Authors:  Marloes Hoeksema; Martin van Eijk; Henk P Haagsman; Kevan L Hartshorn
Journal:  Future Microbiol       Date:  2016-03-04       Impact factor: 3.165

Review 9.  Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

Authors:  Kouichi Miura; Hirohide Ohnishi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Transl Res       Date:  2015-08-14       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.